Pulse Biosciences (PLSE) Operating Leases (2020 - 2025)
Historic Operating Leases for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $7.9 million.
- Pulse Biosciences' Operating Leases fell 570.1% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 570.1%. This contributed to the annual value of $8.9 million for FY2024, which is 269.03% down from last year.
- Latest data reveals that Pulse Biosciences reported Operating Leases of $7.9 million as of Q3 2025, which was down 570.1% from $8.2 million recorded in Q2 2025.
- In the past 5 years, Pulse Biosciences' Operating Leases registered a high of $10.6 million during Q1 2021, and its lowest value of $7.9 million during Q3 2025.
- In the last 5 years, Pulse Biosciences' Operating Leases had a median value of $9.4 million in 2022 and averaged $9.3 million.
- Over the last 5 years, Pulse Biosciences' Operating Leases had its largest YoY gain of 5892.38% in 2021, and its largest YoY loss of 2522.66% in 2021.
- Over the past 5 years, Pulse Biosciences' Operating Leases (Quarter) stood at $8.1 million in 2021, then increased by 24.17% to $10.0 million in 2022, then dropped by 8.92% to $9.1 million in 2023, then fell by 2.69% to $8.9 million in 2024, then decreased by 11.33% to $7.9 million in 2025.
- Its Operating Leases stands at $7.9 million for Q3 2025, versus $8.2 million for Q2 2025 and $8.6 million for Q1 2025.